41S RIO GRANDE STREET, SALT LAKE CITY, UT
Reports First Quarter Financial Results and Provides Business Update
Annual Report to Security Holders
Announces Board Transition
Announces Vicki Goodman, M.D., as Incoming Chief Medical Officer
Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
Investor Presentation
Recursion Pharmaceuticals Files Prospectus Supplement for 7,088,742 Shares
Q1
FY 2024
Q3
Q2
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
S-3ASR
Additional Proxy Materials
Definitive Proxy Statement
Definitive Merger Proxy Statement
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Notice of Proposed Sale of Securities
Prospectus filed pursuant to Rule 424(b)(7)